NCT00174629View on ClinicalTrials.gov

GILT Docetaxel - Non-Small Cell Lung Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

449

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

January 31, 2007

Conditions

Lung Neoplasms

Interventions

DRUG

Docetaxel/DDP

DRUG

docetaxel/gemcitabine

Trial Locations (3)

Unknown

Sanofi-Aventis, Berlin

Sanofi-Aventis, Barcelona

Sanofi-Aventis, Geneva

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY